Victory Capital Management’s Relay Therapeutics RLAY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$796K	Buy	79,994 +64,978	+433%	+$581K	﹤0.01%	1923
2025 Q4	$127K	Buy	15,016 +24	+0.2%	+$171	﹤0.01%	2255
2025 Q3	$78.3K	Sell	14,992 -422	-3%	-$1.61K	﹤0.01%	2316
2025 Q2	$53.3K	Buy	15,414 +16	+0.1%	+$48	﹤0.01%	2374
2025 Q1	$40.3K	Buy	15,398 +151	+1%	+$592	﹤0.01%	2384
2024 Q4	$62.8K	Sell	15,247 -58,639	-79%	-$319K	﹤0.01%	2369
2024 Q3	$523K	Sell	73,886 -2,653	-3%	-$19.8K	﹤0.01%	1995
2024 Q2	$499K	Buy	76,539 +7,680	+11%	+$52.5K	﹤0.01%	1977
2024 Q1	$572K	Buy	68,859 +57,392	+500%	+$560K	﹤0.01%	1939
2023 Q4	$126K	Buy	+11,467	New	+$96.8K	﹤0.01%	2311
2023 Q1	–	Sell	-45,560	Closed	-$681K	–	2677
2022 Q4	$681K	Sell	45,560 -21,570	-32%	-$413K	﹤0.01%	1907
2022 Q3	$1.5M	Sell	67,130 -1,660	-2%	-$36.4K	﹤0.01%	1543
2022 Q2	$1.15M	Buy	68,790 +59,600	+649%	+$1.28M	﹤0.01%	1678
2022 Q1	$219K	Sell	9,190 -556	-6%	-$13.5K	﹤0.01%	2391
2021 Q4	$299K	Buy	9,746 +1,403	+17%	+$44.3K	﹤0.01%	2384
2021 Q3	$263K	Sell	8,343 -776	-9%	-$26.1K	﹤0.01%	2426
2021 Q2	$334K	Buy	9,119 +1,955	+27%	+$64.4K	﹤0.01%	2381
2021 Q1	$248K	Sell	7,164 -878	-11%	-$38.1K	﹤0.01%	2466
2020 Q4	$334K	Buy	+8,042	New	+$364K	﹤0.01%	2246

Other funds holding RLAY